The Valley Desk

NCT02945046 · Interventional trial

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Overall registry status Terminated

Phase 3

Conditions Episodic Cluster Headache

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov